What the American Heart Association Won't Tell You about Heart Disease

By Shereen Noon

Now that Chelation Therapy has been statistically proven to work on heart disease, especially diabetic heart disease by the National Institutes of Health, we see how the American Heart Association, mainstream media, and BigPharma are making sure you don't find out that you can make more intelligent choices over your health and well-being.

This book contains the transcription of the revealing documentary, "Unleaded," that exposes the story of the NIH's 10 year and $31 million dollar and how the astonishing results of the definitive double-blind randomized study are being swept under the rug to make sure you keep buying into ineffective, and sometimes harmful prescriptions, stents and heart surgery, and continued financial and emotional suffering.

• Language: English
• Publisher: Shereen Noon
• Release date: Aug 4, 2014
• ISBN: 9780962469022

Shereen Noon

Film director, author, entrepreneur, inventor, and artist Shereen Noon grew up in the Midwest, travelled internationally, worked in film in Los Angeles, and currently lives in Santa Fe, New Mexico. Always compelled to tell stories through writing and film that have the ability to change major paradigms, Noon has directed two feature documentaries; “Body: The Value of Women” and “Unleaded – What the American Heart Association Doesn’t want you to Know about Heart Disease.” “Body” takes a look at why women feel the way they do about themselves; whether they be thin actresses and models or large women over 300 pounds. “Unleaded” exposes traditional medicine’s resistance to what has just been statistically proven to work in improving heart disease, the number one killer of people over 35 years old globally. Exposing chronic manipulation and abuse for profit, regardless of the resulting human suffering excites Noon as she expands her work into the intersection of film and publishing.

Book preview

Chapter 14

Leading Theories on How Chelation Works

Chapter 15

Patient Results

Chapter 16

Five Months Later: JAMA Finally Publishes TACT Statistics

Chapter 17

NIH TACT Study Statistical Updates by Dr. Roy Heilbron

Epilogue

We Wish to Thank

APPENDIX A

Recommended Reading

APPENDIX B

Recommended Films

APPENDIX C

Recommended YouTube Videos

Disclaimer

The medical information provided here is of a general nature and cannot substitute for the advice of a medical professional for individual problems or for making an evaluation as to the risks and benefits of a particular health protocol.

Readers should consult their healthcare providers before adopting any of the information in this book or from watching the documentary Unleaded, assuming any meaning or incorporating it into their lives. No information presented should be construed as an attempt to offer a medical opinion or otherwise engage in the practice of medicine.

Prologue

I hadn’t planned on directing another feature documentary film. Our film, Body: The Value of Women was already successfully distributed to libraries, clinics, universities, and women’s studies departments globally. But, when I met Dr. Hart and Dr. Heilbron in Santa Fe, New Mexico, they told me how the American Heart Association refused to recommend Chelation Therapy which improves heart disease, regardless of the astonishingly high statistical results of the definitive double blind study. I was outraged and immediately leaned over and asked them if Elemental Films® could do a documentary on the story. They said yes.

At only 65, my father died on the operating table during triple bypass surgery after being on the table for 13 hours. My mother has had two heart attacks since. If they’d known about Chelation Therapy, my father might still be alive and my mother might not be suffering needlessly like this.

So began a year of directing and editing the feature documentary, Unleaded, exposing the mainstream media and traditional medicine, including the FDA, for making sure that we increasingly and unnecessarily suffer physically, financially, and emotionally, as we in the U.S., pay trillions of dollars to hospitals and billions of dollars to BigPharma. At the end of all that, we get to die young from a growing killer – heart disease. Fifty percent of deaths now are caused by heart disease.

Fortunately, there’s stunning new evidence from the National Institutes of Health that Chelation Therapy dramatically improves our chances. In their government sponsored 10 year $31 million Trial to Assess Chelation Therapy (TACT,) the NIH finally revealed the results that Chelation Therapy does indeed work for improving heart disease, diabetic heart disease, and heart attacks.

On November 4, 2012, Dr. Gervasio Lamas, the director of the NIH study, presented the TACT results at the American Heart Association’s (AHA) Annual Scientific Sessions in Los Angeles, proving definitively that Chelation Therapy, if taken with the recommended vitamins, improves heart disease by 26%, improves diabetic heart disease by an astonishing 39%, and reduced heart attacks by 23%.

This is especially good news for women. The facts are that heart disease is the leading cause of death for women in the United States, and 64% of women who die suddenly of coronary heart disease have no previous symptoms.

Chelation Therapy is an affordable treatment (about $3,000-5,000) which removes lead, mercury, arsenic, and other heavy metals from our bodies. They’re discovering now that heavy metals and toxins create inflammation, which eventually leads to disease. Due to our air, food, water, and especially our mercury fillings (lovingly inserted by our respected and trusted dentists) almost everyone has high heavy metal levels – and there are no safe levels, period.

Immediately following Dr. Lamas’ TACT presentation, Elliott Antman, MD, the Director of the AHA, announced that